Furthermore, accurate quantification of CRP and IL-6 in sepsis and COVID-19 may be crucial for predicting outcomes, thus potentially enabling early therapeutic interventions and therapy control, e.g., in response to mechanical ventilation or Tocilizumab treatment [11–13]. The gene discussed is CRP; the disease is Sepsis.